Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSPE.L Regulatory News (SPE)

  • There is currently no data for SPE

AGM Statement

16 Jun 2009 07:00

Embargoed Release: 07:00hrs Tuesday 16 June 2009

SOPHEON PLC AGM Statement

At the Annual General Meeting of Sopheon plc to be held later today, the chairman of the board will give shareholders an update and review of the business. This will include the following statement:

"Sopheon delivered a landmark performance in 2008. We reported revenues of £ 9.3m, a year-over-year increase of 47%. We also showed good improvement in profitability. Since the start of 2009, we have closed a total of 15 new and extension license orders. The total licensee base now stands at 163 and recurring revenues from maintenance, hosting and rental licenses now stand at £ 4 million compared to £2.9 million a year ago. Revenue visibility for the full year from contracted business and recurring revenue streams, now stands at £ 6.2 million. We had expected to report a higher figure to shareholders at this point in time, however, as noted in our Interim Management Statement of 7 May, our performance in current market conditions remains unpredictable. A number of opportunities that we had expected to close in the second quarter are now unlikely to conclude until the third or fourth quarters of the year. Several of these prospects have attributed the delays to more stringent approval processes imposed due to the current market uncertainty.

The majority of the affected prospects remain in active sales cycles, and a number of them are beginning to indicate early signs of improvement in conditions. Accordingly, we continue to expect to close these opportunities in the second half of the year, in addition to new business originally identified for the third and fourth quarters. This will be a major challenge but one we will embrace with vigour. The impact of the economy aside, such delays are not a new experience for Sopheon. We have consistently noted our business dependency on a small number of relatively large deals, any of which can materially impact the revenue recorded in a particular period. While we do anticipate closing further business in June, a possible effect of the ongoing delays is that revenues in the first half of 2009 may be lower than those recorded in the comparable period last year. With higher costs due to higher staff levels (particularly in product development) and the impact of the weakness of Sterling, this is expected to result in an EBITDA loss for the first half of the year. In our announcement of 7 May we noted that while we had expanded investment in product development, we had taken action to reduce and reorganize certain operational groups. The financial benefit of this adjustment will feed through into the second half the year. However, as a prudent measure in these unpredictable times, we are evaluating further cost adjustments, as well as negotiating improved cash facilities.

As we face the current challenges, we are fortified by our recent achievements. Over the last two years we have evolved Sopheon from a single product company to one with a product family of three. This has been accomplished through a combination of strategic investment, partnership activity and an unremitting focus on product development. Our first milestone in this expansion in scope was in 2007 with the acquisition of Alignent Software, bringing its Vision Strategist roadmapping solution into our product set. This was followed last year with the pivotal release of version 7.0 of our core Accolade platform. Most recently, we announced the launch of Idea Lab, our new idea development software, which has expanded the capacity of our solution set to strengthen the front-end of the product innovation process. With this launch, Sopheon now offers the first software suite in the industry to provide all-in-one support that encompasses innovation strategy, ideation and execution. We remain convinced that this represents a highly differentiated value proposition, and are encouraged by strong interest from the market and influential, positive affirmation from the business analyst community."

-Ends-

For further information contact:

Barry Mence, Chairman Sopheon plc + 44 (0) 1483 685 735

Arif Karimjee, CFO Vikki Krause Hansard Communications + 44 (0) 207 245 1100 + 44 (0) 7515 922906 Claire Verhagen Citigate First Financial + 31 (0) 205 754 010 Sarah Jacobs Seymour Pierce + 44 (0) 207 107 8000 About Sopheon

Sopheon is an international provider of software and services that help organisations improve the business impact of product innovation. Sopheon's solutions automate and govern the innovation process, enabling companies to increase revenue and profits from new products. Sopheon's solutions are used by industry leaders throughout the world, including BASF, Cadbury Schweppes, Corning, Electrolux, General Motors, Honeywell, Motorola and SAB Miller. Sopheon is listed on the AIM Market of the London Stock Exchange and on the Euronext in the Netherlands. For more information, please visit www.sopheon.com.

vendor
Date   Source Headline
27th Jan 20117:00 amPRNTrading Statement
9th Dec 20107:00 amPRNAmendment to the Terms of Convertible Loan Stock
16th Nov 20107:00 amPRNContract Win
4th Nov 20107:00 amPRNInterim Management Statement
27th Aug 201010:30 amPRNGrant of Options
26th Aug 20107:00 amPRNHalf-yearly Report
22nd Jul 20107:00 amRNSTrading Update
15th Jun 20105:31 pmPRNResult of AGM
15th Jun 20107:00 amPRNAGM Statement
18th May 20107:00 amRNSAfton Chemical Selects Idea Lab
6th May 20107:00 amPRNInterim Management Statement
25th Mar 20107:00 amPRNFinal Results
22nd Mar 20107:00 amRNSiSUSTAINT Alliance Launched
3rd Feb 20107:00 amRNSSopheon Team wins TARDEC Contract
28th Jan 20107:00 amPRNTrading Update
24th Dec 20097:01 amRNSExtension of GEM Equity Line
2nd Dec 20097:00 amRNSVision Strategist Version 5.0 Launched
3rd Nov 20097:00 amPRNInterim Management Statement
2nd Oct 20093:43 pmPRNISSUE OF CONVERTIBLE LOAN STOCK
27th Aug 20097:00 amPRNHalf-yearly Report
16th Jun 200912:34 pmPRNResult of AGM
16th Jun 20097:00 amPRNAGM Statement
19th May 20097:00 amPRNProduct Launch
7th May 20097:00 amPRNInterim Management Statement
26th Mar 20097:00 amPRNFinal Results
18th Mar 20097:00 amRNSBostik Implements Sopheon's Accolade System
11th Mar 20097:00 amRNSContract Win
11th Feb 20097:00 amRNSEnhanced Version of Accolade? Launched
28th Jan 20097:00 amPRNTrading Update
21st Jan 20097:00 amRNSSopheon Partners with Maxsoft
4th Nov 20087:00 amPRNInterim Management Statement
28th Aug 20087:00 amPRNHalf-yearly Report
27th Jun 20083:47 pmPRNDirector/PDMR Shareholding
25th Jun 20087:00 amPRNGrowth Milestone
10th Jun 20087:00 amPRNAGM Statement
16th May 20087:00 amPRNDirector/PDMR Shareholding
15th May 20087:00 amPRNInterim Management Statement
6th May 200810:00 amPRNNotice of AGM
29th Apr 20087:02 amRNSContract Win
1st Apr 200810:00 amPRNGrant of Options
27th Mar 20087:00 amPRNFinal Results
6th Feb 20087:01 amRNSProduct Development
25th Jan 20087:00 amPRNTrading Update
21st Dec 200710:30 amPRNTrading Update
25th Oct 20077:00 amPRNTrading Update
16th Oct 20072:38 pmBUSBeiersdorf Implements Sopheon System in Support of Product Innovation Strategy
16th Oct 20077:01 amRNSContract Win
10th Oct 20072:45 pmBUSLeading European Center for Clinical Trials Research Selects Sopheon's Accolade(R) System
10th Oct 20077:01 amRNSContract Win
1st Oct 20077:02 amRNSContract Win

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.